(Q46910533)
Statements
(2R,3R)-2-(3',4'-dihydroxybenzyl)-3-(3'',4''-dimethoxybenzyl)butyrolactone suppresses fMLP-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils (English)
Yi-Jia Huang
Yuan-Ji Day
6 October 2007